CITIC Securities (06030) reported a net profit attributable to shareholders of 30.051 billion yuan for the fiscal year 2025, representing a year-on-year increase of 38.46%. Wuxi XDC (02268) announced an expected year-on-year growth of over 38% in net profit for the fiscal year 2025.
Material Events:
Longqi Technology (09611) announced its initial public offering from January 14 to January 19, planning to globally offer 52.2591 million H-shares.
Hutchmed (00013) announced the publication of the results of the SACHI Phase III study in The Lancet.
Dongyangguang Pharmaceutical (06887) launched an AI-powered R&D platform targeting PROTAC mechanisms, further deepening its AI strategic layout.
Towa Pharm-B (01875) received a cash offer from Wuxi XDC (02268) at a premium of approximately 99%, resuming trading on January 15.
Vigilab-B (09887): Velixin (PD-L1/4-1BB bispecific antibody Aupatizumab, LBL-024) has been granted Fast Track Designation by the U.S. FDA.
Xunce (03317) entered into a strategic cooperation framework agreement with Jinyong Investment to support the digital transformation of investment research, trading, and risk management.
Operating performance:
CITIC Securities (06030) reported a net profit attributable to shareholders of 30.051 billion yuan for the 2025 fiscal year, representing a year-over-year increase of 38.46%.
CITIC Bank (00998) reported a net profit attributable to shareholders of 70.618 billion yuan in 2025, representing a year-on-year increase of 2.98%.
CGN New Energy (01811) reported a cumulative power generation of 19,000 GWh in 2025, representing a year-on-year decrease of 0.8%.
Yuexiu Property (00123) announced cumulative contractual sales of approximately 106.21 billion yuan for the 2025 fiscal year.
Wuxi XDC (02268) issued a positive earnings forecast, expecting a net profit increase of over 38% year-over-year for the 2025 fiscal year.
Jinyu Group (02009) issued a profit warning, projecting a net loss attributable to shareholders of 900 million to 1.2 billion yuan for 2025.
Saijing Technology (00580) issued a positive earnings forecast, anticipating a year-over-year net profit increase of approximately 30.0% for the 2025 fiscal year.
Beijing North Star Co., Ltd. (00588) issued a profit warning, expecting a net loss attributable to shareholders of RMB 2.696 billion to RMB 3.38 billion for 2025.
